Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    PDS Biotechnology Corpora...

    NASDAQ: PDSB · Real-Time Price · USD
    1.80
    0.02 (1.12%)
    At close: Jun 17, 2025, 10:06 AM

    PDS Biotechnology Statistics

    Share Statistics

    PDS Biotechnology has 45.71M shares outstanding. The number of shares has increased by 21.57% in one year.

    Shares Outstanding

    n/a
    		 45.71M

    Shares Change (YoY)

    n/a
    		 21.57%

    Shares Change (QoQ)

    n/a
    		 19.19%

    Owned by Institutions (%)

    n/a
    		 11.52%

    Shares Floating

    n/a
    		 43.98M

    Failed to Deliver (FTD) Shares

    n/a
    		 16,593

    FTD / Avg. Volume

    n/a
    		 3.49%

    Short Selling Information

    The latest short interest is 2.9M, so 6.35% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.9M

    Short % of Shares Out

    n/a
    		 6.35%

    Short % of Float

    n/a
    		 6.55%

    Short Ratio (days to cover)

    n/a
    		 2.46

    Valuation Ratios

    The PE ratio is -1.58 and the forward PE ratio is -2.05. PDS Biotechnology's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.58

    Forward PE

    n/a
    		 -2.05

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 3.13

    P/FCF Ratio

    n/a
    		 -1.69

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for PDS Biotechnology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.64, with a Debt / Equity ratio of 1.15.

    Current Ratio

    n/a
    		 2.64

    Quick Ratio

    n/a
    		 2.64

    Debt / Equity

    n/a
    		 1.15

    Debt / EBITDA

    n/a
    		 -0.65

    Debt / FCF

    n/a
    		 -0.62

    Interest Coverage

    n/a
    		 -7.77

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,567,083.33

    Employee Count

    n/a
    		 24

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -869K

    Effective Tax Rate

    n/a
    		 2.26%

    Stock Price Statistics

    The stock price has increased by -33.33% in the last 52 weeks. The beta is 1.24, so PDS Biotechnology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.24

    52-Week Price Change

    n/a
    		 -33.33%

    50-Day Moving Average

    n/a
    		 1.34

    200-Day Moving Average

    n/a
    		 1.99

    Relative Strength Index (RSI)

    n/a
    		 65.54

    Average Volume (20 Days)

    n/a
    		 475,785

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -59.79K

    Operating Income

    n/a
    		 -36.32M

    Net Income

    n/a
    		 -37.61M

    EBITDA

    n/a
    		 -33.75M

    EBIT

    n/a
    		 -33.81M

    Earnings Per Share (EPS)

    n/a
    		 -1079.45
    Full Income Statement

    Balance Sheet

    The company has 41.69M in cash and 21.83M in debt, giving a net cash position of 19.86M.

    Cash & Cash Equivalents

    n/a
    		 41.69M

    Total Debt

    n/a
    		 21.83M

    Net Cash

    n/a
    		 19.86M

    Retained Earnings

    n/a
    		 -182.11M

    Total Assets

    n/a
    		 47.03M

    Working Capital

    n/a
    		 24.2M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -35.03M and capital expenditures -29K, giving a free cash flow of -35.06M.

    Operating Cash Flow

    n/a
    		 -35.03M

    Capital Expenditures

    n/a
    		 -29K

    Free Cash Flow

    n/a
    		 -35.06M

    FCF Per Share

    n/a
    		 -0.96
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PDSB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PDSB is $10, which is 461.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 461.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 18, 2019. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Mar 18, 2019

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -5.92

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist